[27I-am] Targeting-2

Sun. Mar 27, 2022 10:42 AM - 11:54 AM [Room I] Conference Room 222 (Bldg. 2: 2F)

Chair: Shigeru Kawakami

+Add all to schedule

10:42 AM - 10:54 AM

[27I-am07] Development of glucose-PEG conjugated immune checkpoint inhibitors for glioma therapy

○Yuki Mochida¹, Tao Yang¹, Xueying Liu¹, Hiroaki Kinoh¹, Horacio Cabral², Kazunori Kataoka¹ (1. iCONM, Kawasaki Inst. of Ind. Promotion, 2. Grad. Sch. of Eng., The Univ. of Tokyo)

10:54 AM - 11:06 AM

[27I-am08S] Development of the nanoparticles modified with fibrotic tissue binding peptide for targeting to fibrotic kidneys

○Yuki Nakamura¹, Kohei Togami^1,2, Chono Sumio^1,2 (1. Faculty of Pharmaceutical Science, Hokkaido University of Science, 2. Creation Research Institute of Life Science in KITA-no-DAICHI)

11:06 AM - 11:18 AM

[27I-am09] Development of splenic marginal zone B cell-targeted vaccine for the induction of antibody against SARS-CoV-2

○Taro Shimizu¹, Sesshu Yamaguchi¹, Hidenori Ando¹, Yu Ishima¹, Tatsuhiro Ishida¹ (1. Institute of Biomedical Sciences, Tokushima University)

11:18 AM - 11:30 AM

[27I-am10S] Transfer of Lipid Nanoparticle with Cell Penetrating Peptides

○Koichi Yamaguchi¹, Motofumi Goto¹, Shino Kinugasa¹, Ryo Morofuji^1,2, Komei Okabe^1,2, Kazuhiro Kudo^1,2, Takahiro Honda^1,2 (1. NAIST, 2. Santen Pharmaceutical Co.)

11:30 AM - 11:42 AM

[27I-am11S] Intranasal administrated GLP-1 derivative transfer nerve cells and show its effect at lower doses than i.c.v. administration

○Mizuki Yasui¹, Ayano Tezuka¹, Yusuke Oda¹, Yuma Saiki¹, Tomomi Akita¹, Chikamasa Yamashita¹ (1. Grad. Sch. Pharm. Sci., Tokyo Univ. Sci.)

11:42 AM - 11:54 AM

[27I-am12S] Evaluation of tissue and brain distribution of antisense oligonucleotide after administration in the form of DNA/RNA heteroduplex oligonucleotides

○Natsuki Makiguchi¹, Yukitake Yoshioka¹, Yanran Tong¹, Kosuke Kusamori¹, Syunsuke Yamamoto², Hideki Hirabayashi², Takanori Yokota³, Makiya Nishikawa¹ (1. Fac. Pharm. Sci., Tokyo Univ. Sci., 2. Takeda Pharmaceutical Co., Ltd., 3. Tokyo Med. Dent. Univ.)

Session information